ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 344

Use of Lean Six-Sigma Methodologies to Improve Pneumococcal Vaccination Rates Among Immunocompromised Veterans with Rheumatologic Diseases: A Quality Improvement Project

Melissa Swee1, Jaime Wilson2 and Bharat Kumar3, 1Transplant Nephrology, University of Iowa, Iowa City, IA, 2Iowa City Veterans Affairs Medical Center, Iowa City, IA, 3Internal Medicine-Division of Immunology, University of Iowa, Iowa City, IA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: prevention, Quality improvement and vaccines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pneumonia is a leading cause of morbidity and mortality in the United States among immunocompromised individuals with rheumatologic diseases. Despite the publication of Advisory Committee on Immunization Practices (ACIP) guidelines for pneumococcal vaccinations addressing the specific needs of this population, implementation of these guidelines has been inconsistent. At one Midwestern VA Rheumatology Clinic, pneumococcal vaccination rates were determined to be as low as 3%. From January to June 2018, we used Lean Six Sigma methodologies to improve the current process surrounding pneumococcal vaccination in the Rheumatology Clinic.

Methods: Current processes and improvement targets for pneumococcal vaccine administration were explored using Lean-six sigma methods: 1) interdisciplinary process mapping; 2) process maps analysis, Voice of the Customer (VOC), and brainstorming for value and flow analyses; 3) value stream maps and pilot testing utilizing PDSA (Plan-Do-Study-Act) cycles; and 4) post-implementation control and sustainability planning. The interprofessional team consisted of a nurse and physician leader, a physician champion, and clinic management. The first set of PDSA cycles involved educating providers and posting the ACIP guidelines in each patient room. The second set of PDSA cycles involved bundling and relocating supplies to a more convenient location. Outcome measures were defined as time required to administer vaccine and percentage of eligible patients who are up-to-date with pneumococcal vaccination. Balancing measures included total time spent in clinic and vaccine adverse reactions.

Results: Process mapping revealed eight barriers. Process redesign resulted in elimination of five of these barriers through workflow simplification. A nurse alert step was added to further improve efficiency. The VOC indicated value in the delivery of high quality care and improving vaccination rates, but without spending excess time in the vaccine administration workflow. Interim results show improvement in outcome measures, including reduced time required for vaccine administration from 15 to 7 minutes, and increased percentage of patients appropriately immunized from 3% to 21%. Vaccine administration added fewer than 15 minutes to total appointment time and no adverse reactions occurred.

Conclusion: A bundle of quality improvement efforts utilizing lean six sigma methodologies increased the pneumococcal vaccination rate from 3% to 21% and reduced the time required for vaccination from 15 to 7 minutes. Elements of the bundle included: (1) clinician education, (2) posting of an easy-to-read version of the guidelines for vaccine administration, (3) simplification of workflow for administration of pneumococcal vaccines, and (4) integration and bundling of supplies necessary for vaccination. This bundle can be replicated at other sites using similar methodologies. The investigators intend on continuing through more iterations of these PDSA Cycles to achieve a goal of at least 70% appropriate pneumococcal vaccination among immunocompromised patients at the Iowa City VA Rheumatology Clinic.


Disclosure: M. Swee, None; J. Wilson, None; B. Kumar, None.

To cite this abstract in AMA style:

Swee M, Wilson J, Kumar B. Use of Lean Six-Sigma Methodologies to Improve Pneumococcal Vaccination Rates Among Immunocompromised Veterans with Rheumatologic Diseases: A Quality Improvement Project [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/use-of-lean-six-sigma-methodologies-to-improve-pneumococcal-vaccination-rates-among-immunocompromised-veterans-with-rheumatologic-diseases-a-quality-improvement-project/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-lean-six-sigma-methodologies-to-improve-pneumococcal-vaccination-rates-among-immunocompromised-veterans-with-rheumatologic-diseases-a-quality-improvement-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology